A comprehensive study reveals that the Pfizer–BioNTech COVID-19 vaccine poses fewer risks than the actual infection in children, underscoring its importance in combating the coronavirus pandemic.
- The study, published in The Lancet, highlights that post-infection risks, such as myocarditis and pericarditis, persist significantly longer than side effects following vaccination.
- Researchers found that while the Pfizer–BioNTech COVID-19 vaccine has been linked to instances of inflammation, the dangers associated with infection are more severe for children and young people.
- During the pandemic, concerns arose regarding the safety of the vaccine, but this study confirms its relative safety compared to the potentially life-threatening consequences of coronavirus infection.
Why It Matters
This study is crucial as it reassures parents about the safety of the Pfizer–BioNTech COVID-19 vaccine, encouraging vaccination among children and ultimately contributing to public health efforts against the coronavirus.